Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 892,756 shares at $5.23 ($4.7M) on 2024-09-10, disclosed to the SEC on 2024-09-11.
Open-market sale of $4.7M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.42 | 157,704 | $855K | 18.1% |
| 2 | $5.42 | 157,704 | $855K | 18.1% |
| 3 | $5.23 | 288,674 | $1.5M | 31.9% |
| 4 | $5.23 | 288,674 | $1.5M | 31.9% |
| Total | $5.30 avg | 892,756 | $4.7M | 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |
| HUMA | SELL | 2024-08-29 | $11.4M | — | Filing → |